Cargando…
Exploiting changes in the tumour microenvironment with sequential cytokine and matrix metalloprotease inhibitor treatment in a murine breast cancer model
The study of treatment-induced changes in the tumour microenvironment might lead to effective combinations of biological therapy. IL-12 induced tumour regression and cure of an experimental murine breast cancer, HTH-K, but only after long-term treatment that was associated with chronic toxicity. Dur...
Autores principales: | Scott, K A, Holdsworth, H, Balkwill, F R, Dias, S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363423/ https://www.ncbi.nlm.nih.gov/pubmed/11076665 http://dx.doi.org/10.1054/bjoc.2000.1487 |
Ejemplares similares
-
Induction of matrix metalloprotease-1 gene expression by retinoic acid in the human pancreatic tumour cell line Dan-G
por: Marschall, Z von, et al.
Publicado: (1999) -
Modulation of matrix metalloproteases by ciliary neurotrophic factor in human placental development
por: Tossetta, Giovanni, et al.
Publicado: (2022) -
Sequential morphological characteristics of murine fetal liver hematopoietic microenvironment in Swiss Webster mice
por: Ayres-Silva, Jackline de Paula, et al.
Publicado: (2011) -
Evaluation of indomethacin as matrix metalloproteases inhibitor in human dentin
por: Shailendra, Mashalkar, et al.
Publicado: (2019) -
Do Matrix Metalloproteases and Tissue Inhibitors of Metalloproteases in Tenocytes of the Rotator Cuff Differ with Varying Donor Characteristics?
por: Klatte-Schulz, Franka, et al.
Publicado: (2015)